Disruptor of telomeric silencing 1-like (DOT1L) is involved in breast cancer metastasis via transcriptional regulation of MALAT1 and ZEB2. (20th December 2019) - Duan, Yang; Zhang, Xingyan; Yang, Lihong; Dong, Xu; Zheng, Zhanye; Cheng, Yiming; Chen, Hao; Lan, Bei; Li, Dengwen; Zhou, Jun; Xuan, Chenghao